The Albumin market is projected to grow at a CAGR of 7% by 2033.
The Albumin market growth drivers include rising demand for plasma-derived medicines, expanding therapeutic applications, and growth in critical care treatments.
North America is a dominating region for the Albumin market.
CSL Behring, Grifols S.A., Takeda Pharmaceutical Company Limited, Octapharma AG, and Baxter International Inc. are some leading industry players in the Albumin market.